Literature DB >> 17188795

Mitochondrial trafficking and morphology in healthy and injured neurons.

Diane T W Chang1, Ian J Reynolds.   

Abstract

Mitochondria are the primary generators of ATP and are important regulators of intracellular calcium homeostasis. These organelles are dynamically transported along lengthy neuronal processes, presumably for appropriate distribution to cellular regions of high metabolic demand and elevated intracellular calcium, such as synapses. The removal of damaged mitochondria that produce harmful reactive oxygen species and promote apoptosis is also thought to be mediated by transport of mitochondria to autophagosomes. Mitochondrial trafficking is therefore important for maintaining neuronal and mitochondrial health while cessation of movement may lead to neuronal and mitochondrial dysfunction. Mitochondrial morphology is also dynamic and is remodeled during neuronal injury and disease. Recent studies reveal different manifestations and mechanisms of impaired mitochondrial movement and altered morphology in injured neurons. These are likely to cause varied courses toward neuronal degeneration and death. The goal of this review is to provide an appreciation of the full range of mitochondrial function, morphology and trafficking, and the critical role these parameters play in neuronal physiology and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188795     DOI: 10.1016/j.pneurobio.2006.09.003

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  108 in total

Review 1.  Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration.

Authors:  Jorge M A Oliveira
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

2.  Mitochondrial Ca(2+) mobilization is a key element in olfactory signaling.

Authors:  Daniela Fluegge; Lisa M Moeller; Annika Cichy; Monika Gorin; Agnes Weth; Sophie Veitinger; Silvia Cainarca; Stefan Lohmer; Sabrina Corazza; Eva M Neuhaus; Werner Baumgartner; Jennifer Spehr; Marc Spehr
Journal:  Nat Neurosci       Date:  2012-03-25       Impact factor: 24.884

3.  Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia.

Authors:  Yujiro Shidara; Peter J Hollenbeck
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 4.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

5.  Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters.

Authors:  Lyle Wiemerslage; Daewoo Lee
Journal:  J Neurosci Methods       Date:  2016-01-14       Impact factor: 2.390

Review 6.  Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.

Authors:  Xiongwei Zhu; George Perry; Mark A Smith; Xinglong Wang
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  Moving mitochondria: establishing distribution of an essential organelle.

Authors:  Rebecca L Frederick; Janet M Shaw
Journal:  Traffic       Date:  2007-10-17       Impact factor: 6.215

8.  Effects of imaging conditions on mitochondrial transport and length in larval motor axons of Drosophila.

Authors:  Kathryn Louie; Gary J Russo; David B Salkoff; Andrea Wellington; Konrad E Zinsmaier
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2008-06-27       Impact factor: 2.320

9.  Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein.

Authors:  Martin Cente; Stanislava Mandakova; Peter Filipcik
Journal:  Cell Mol Neurobiol       Date:  2009-03-17       Impact factor: 5.046

10.  Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Stephen I Lentz; Lucy M Hinder; Samuel W Jackson; Andrew Valesano; Gideon E Levinson; Eva L Feldman
Journal:  FASEB J       Date:  2017-09-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.